FCC approves Anterix and Lynk Global test of 900 MHz satellite communications

Anterix (NASDAQ: ATEX) and Lynk Global received Federal Communications Commission approval for an experimental license to test satellite direct-to-device communications using Anterix's licensed 900 MHz broadband spectrum.

The companies will test various communications devices across multiple geographic locations, including land mobile radios, smartphones, computers, routers and edge devices. The testing aims to explore integration of Lynk's satellite capabilities with Anterix's 900 MHz private wireless broadband networks.

The experimental program targets critical infrastructure sectors including electric and gas utilities, logistics companies, transportation providers, pipelines and military bases. The companies stated the convergence of wireless and satellite connectivity could enable nationwide intelligent and resilient connectivity.

"Testing the integration of 900 MHz-enabled devices with Lynk's satellite capabilities will give us incredible insight into the products and services that could be developed, possibly opening the door to a new category of private, secure, resilient network services," said Christopher Guttman-McCabe, Anterix Chief Regulatory & Corporate Communications Officer.

Amy Mehlman, Lynk Global Executive Vice President & Chief Global Affairs Officer, said the collaboration investigating integration of dedicated low-band spectrum into Lynk's satellite platform represents an opportunity to deliver integrated satellite-terrestrial connectivity solutions for critical infrastructure operators.

Anterix operates in mission-critical private wireless broadband networks using 900 MHz licensed spectrum. Lynk Global provides satellite direct-to-device services and claims partnerships with over 50 mobile network operators across more than 50 countries.

The information is based on a press release statement from the companies.

You May Also Be Interested In

• FactSet invests in Tifin.AI to build AI tools for wealth advisors
• Polyrizon gets IRB approval for NASARIX allergy blocker trial
• Patriot Bank opens Beverly Hills branch with $100M in deposits